Changing Paradigm in Diagnostic Pathology of Epithelial Ovarian Cancer


Global Journal of Reproductive Medicine   Juniper Publishers


Authored by: Poonam Elhence*

Abbreviations

Abbreviations: EOC: Epithelial Ovarian Cancer; HGSC: High-Grade Serous Carcinoma; CA-125: Cancer Antigen-125; HE4: Human Epididymis Protein 4

Short Communications

Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological malignancies. Due to late presentation and diagnosis at an advanced stage, the mortality rate from ovarian cancer continues to be high. A lot of research for development of specific newer biomarkers for diagnosis and prognosis in EOC is occurring at a rapid pace. EOC is a highly heterogeneous disease characterized by many diverse histological and molecular subtypes [1]. Morphologically, these tumours are typed into serous, mucinous, endometrioid, clear cell, brenner and seromucinous types. These are then further divided into benign, borderline and malignant depending on the degree of cell proliferation, nuclear atypia and presence or absence of stromal invasion [2]. Molecular characterization of EOC has led to a simplified dualistic model of classification into either type I or type II tumors, with implications for pathogenesis, clinical features and prognosis [3]. Over two- thirds of the ovarian epithelial tumours have serous histology and the other subtypes are much less common as compared with high-grade serous carcinoma (HGSC) [4].
The use of biomarkers not only helps to diagnose but also prognosticates patients and predicts better patient response [5]. The most commonly employed test in patients suspected to have EOC is serum Cancer antigen-125 (CA-125) levels. This test is used for the screening and diagnosis of ovarian cancer. But, raised serum levels may be seen in benign conditions including ovarian cysts and in pregnancy while some early stage EOC do not show increase in CA-125 levels. Hence, there is poor reproducibility and a trade-off between specificity and sensitivity. Human epididymis protein 4 (HE4), a product of the WFDC2 gene is used for early detection of EOC and it is also purported to have better potential than CA-125 in monitoring EOC patients [6]. In EOC, the differential expression of immunological markers related to the PD-1/PD-L1 pathway in blood can be used as potential diagnostic and prognostic marker and thus, have implication for therapeutic purposes [7]. Many studies have demonstrated use of multiplexed biomarkers to be more reliable than using a single protein biomarker [8].
Genetic biomarkers have been developed employing a host of methods, leading to an improvement in diagnosis, prognosis and therapeutics. Gene alterations in MAPK pathway, CDKN2A, PIK3CA, and PTEN etc. are seen particularly in type I lesions. High frequency of inactivating mutations in ARID1A in ovarian clear cell carcinomas and amplification of ERBB2 have been reported in mucinous tumors and clear cell carcinomas of the ovary.
TP53 mutations are rarely expressed in low grade serous tumours except for mucinous carcinomas while a high frequency of TP53 gene mutations are seen in HGSC. Most HGSCs show immune positivity for WT1, and p16 and exhibit a high Ki- 67 proliferation index [9,10]. The most apparent genetic risk factors in EOC are the germline mutations in BRCA1 and BRCA2 genes. Efforts to develop and identify newer diagnostic tools to provide accurate and detailed information for early diagnosis of EOC are required. Meanwhile, routine serological testing for CA-125 levels, testing for circulating or cell free DNA, genetic and molecular biomarker assays and imaging are carried out to identify specific tumour characteristics and to potentially identify patients at a higher risk for developing EOC and hence, have implications for preventive strategies.

Comments

Post a Comment

Popular posts from this blog

Harlequin Baby with Mild Skin Disorder: Two Years Follow Up

Image
Global Journal of Reproductive Medicine    Juniper Publishers Authored by:  Ismail Biyik*  Abstract Harlequin ichthyosis is a member of nonsyndromic inherited ichthyosis. Neonates born with HI have generally poor prognosis. In this case report, a case of harlequin delivered at the 37th gestational week was presented. Antibiotic prophylaxis was given to the baby with emoillent creams in the newborn period. The boy is now 2.5 years old and does not have a disease other than scaly skin. The child continues to receive emoillent cream treatment. However HI has a high mortality rate during the newborn period, we believe that early antibiotic prophylaxis and the application of softening creams may prevent mortality. Go to Introduction The ichthyoses is a keratinization disorder of skin. These disorders are heterogeneous group. The great majority of ichthyoses are inherited. Harlequin Ichthyosis (HI) is a member of nonsyndromic inherited ichthyosis. H...
Read more

Sperm-Oviduct Interaction Factors that Compromise Fertility of Frozen Stallion Semen

Global Journal of Reproductive Medicine   Juniper Publishers Abstract The cryopreservation procedure changes the integrity and functionality of sperm, affecting their longevity and the ability to fertilize the oocyte. Moreover, some of those changes could be alter the physiologic interactions between the sperm and the oviductal epithelial cells prior to fertilization, placing further limitations and challenges on frozen-thawed stallion sperm. For fertilization to occur, a sperm subpopulation should be survive in uterine environment and be transported to oviduct, the tubular epithelium that regulate the sperm capacitation process in tuning with the ovulation and later oocyte fecundation. Factors affecting sperm-oviduct interactions in equine and findings in other mammals suggest that this interaction is highly conserved. However, there are differences between species and this interaction may assist to explain the idiopathic infertility associated with t...
Read more

Phytoestrogens: A Possible Agent for Controlling Fertility

Global Journal of Reproductive Medicine    Juniper Publishers Authored by:  Debjani Nath* Introduction Phytoestrogens are naturally occurring polyphenolic compounds. They are ubiquitous in human and animal diet. Around 300 plants from more than 16 different plant families have been identified with such a kind of compounds [ 1 , 2 ]. They are structurally and/or functionally bear a close similarity to mammalian estrogens and their active metabolites. Though they are much less potent but their mode of action is similar to 17p-stradiol. The estrogenic compounds are widespread in food. They are found in herbs and seasonings (garlic, parsley), grains (soybeans, wheat, rice), vegetables (beans, carrots, potatoes), fruits (date, pomegranates, cherries, apples), and drinks (coffee) [ 3 ]. So only a totally plant-free diet would prevent exposure to them. We, the human beings as well as animals regularly expose to variable amounts of phytoestrogens mainly through diet...
Read more